Corbus Pharmaceuticals (CRBP) Insider Trading & Ownership → The most important AI company you've never heard of (From Manward Press) (Ad) Free CRBP Stock Alerts $44.14 +1.15 (+2.68%) (As of 05/15/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Corbus Pharmaceuticals (NASDAQ:CRBP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.00%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$33.37 MNumber OfInsiders Selling(Last 12 Months)0 Get CRBP Insider Trade Alerts Want to know when executives and insiders are buying or selling Corbus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRBP Insider Buying and Selling by Quarter Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Corbus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2024Cormorant Asset Management, LpMajor ShareholderBuy250,000$40.05$10,012,500.00 2/2/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.00$14,250,000.00 1/26/2024Cormorant Asset Management, LpMajor ShareholderBuy282,632$32.24$9,112,055.68 (Data available from 1/1/2013 forward) CRBP Insider Trading Activity - Frequently Asked Questions Who is on Corbus Pharmaceuticals's Insider Roster? The list of insiders at Corbus Pharmaceuticals includes Cormorant Asset Management, Lp, Craig Stuart Millian, Sean F Moran, and Yuval Cohen. Learn more on insiders at CRBP. What percentage of Corbus Pharmaceuticals stock is owned by insiders? 4.00% of Corbus Pharmaceuticals stock is owned by insiders. Learn more on CRBP's insider holdings. Which Corbus Pharmaceuticals insiders have been buying company stock? The following insiders have purchased CRBP shares in the last 24 months: Cormorant Asset Management, Lp ($33,374,555.68), Craig Stuart Millian ($1,250.00), Sean F Moran ($8,800.00), and Yuval Cohen ($3,613.00). How much insider buying is happening at Corbus Pharmaceuticals? Insiders have purchased a total of 1,333,932 CRBP shares in the last 24 months for a total of $33,388,218.68 bought. More Insider Trading Tools from MarketBeat Related Companies: Fulcrum Therapeutics Insider Transactions Theravance Biopharma Insider Transactions PepGen Insider Transactions Acelyrin Insider Transactions Lexicon Pharmaceuticals Insider Transactions Biomea Fusion Insider Transactions Entrada Therapeutics Insider Transactions Annexon Insider Transactions Heron Therapeutics Insider Transactions Larimar Therapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:CRBP) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHow to Make 100X on the AI BoomInvestorPlaceShocking $16T Elon Musk Crypto LeakCrypto 101 MediaAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.